Business Description
Shanghai RAAS Blood Products Co Ltd
NAICS : 325414
ISIN : CNE100000C31
Share Class Description:
SZSE:002252: Class ACompare
Compare
Traded in other countries / regions
002252.China IPO Date
2008-06-23Description
Shanghai RAAS Blood Products Co Ltd is a blood products manufacturer in China that has high comprehensive utilization of plasma raw material and a range of products with different specifications. It is engaged in the research, development, and manufacture of blood products and plasma-derived medical products. The company's products include albumin, coagulation factors, and others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1759.25 | |||||
| Equity-to-Asset | 0.93 | |||||
| Interest Coverage | 17737.02 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 14.8 | |||||
| Beneish M-Score | -2.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 24.2 | |||||
| 3-Year EBITDA Growth Rate | 28.1 | |||||
| 3-Year EPS without NRI Growth Rate | 31 | |||||
| 3-Year FCF Growth Rate | 16.2 | |||||
| 3-Year Book Growth Rate | 22.8 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.08 | |||||
| 9-Day RSI | 62.61 | |||||
| 14-Day RSI | 57.52 | |||||
| 6-1 Month Momentum % | 4.75 | |||||
| 12-1 Month Momentum % | 14.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.07 | |||||
| Quick Ratio | 2.45 | |||||
| Cash Ratio | 2.05 | |||||
| Days Inventory | 264.62 | |||||
| Days Sales Outstanding | 31.02 | |||||
| Days Payable | 105.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.41 | |||||
| Dividend Payout Ratio | 0.09 | |||||
| Forward Dividend Yield % | 0.41 | |||||
| 5-Year Yield-on-Cost % | 0.41 | |||||
| 3-Year Average Share Buyback Ratio | -10.7 | |||||
| Shareholder Yield % | 0.43 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.76 | |||||
| Operating Margin % | 29.6 | |||||
| Net Margin % | 27.33 | |||||
| FCF Margin % | 26.69 | |||||
| ROE % | 7.01 | |||||
| ROA % | 6.62 | |||||
| ROIC % | 7.36 | |||||
| ROC (Joel Greenblatt) % | 69.83 | |||||
| ROCE % | 8.43 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.31 | |||||
| PE Ratio without NRI | 21.63 | |||||
| Shiller PE Ratio | 40.22 | |||||
| Price-to-Owner-Earnings | 26.2 | |||||
| PS Ratio | 6.38 | |||||
| PB Ratio | 1.6 | |||||
| Price-to-Tangible-Book | 1.92 | |||||
| Price-to-Free-Cash-Flow | 23.93 | |||||
| Price-to-Operating-Cash-Flow | 19.51 | |||||
| EV-to-EBIT | 17.73 | |||||
| EV-to-EBITDA | 17.73 | |||||
| EV-to-Revenue | 5.83 | |||||
| EV-to-FCF | 21.84 | |||||
| Price-to-Projected-FCF | 1.26 | |||||
| Price-to-Median-PS-Value | 0.2 | |||||
| Price-to-Graham-Number | 1.36 | |||||
| Price-to-Net-Current-Asset-Value | 7.57 | |||||
| Price-to-Net-Cash | 22.47 | |||||
| Earnings Yield (Greenblatt) % | 5.64 | |||||
| FCF Yield % | 4.22 | |||||
| Forward Rate of Return (Yacktman) % | 20.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai RAAS Blood Products Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 7,551.026 | ||
| EPS (TTM) (Â¥) | 0.308 | ||
| Beta | 0.62 | ||
| Volatility % | 31.24 | ||
| 14-Day RSI | 57.52 | ||
| 14-Day ATR (Â¥) | 0.164131 | ||
| 20-Day SMA (Â¥) | 6.975 | ||
| 12-1 Month Momentum % | 14.61 | ||
| 52-Week Range (Â¥) | 5.93 - 8.68 | ||
| Shares Outstanding (Mil) | 6,645.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai RAAS Blood Products Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai RAAS Blood Products Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai RAAS Blood Products Co Ltd Frequently Asked Questions
What is Shanghai RAAS Blood Products Co Ltd(SZSE:002252)'s stock price today?
The current price of SZSE:002252 is ¥7.19. The 52 week high of SZSE:002252 is ¥8.68 and 52 week low is ¥5.93.
When is next earnings date of Shanghai RAAS Blood Products Co Ltd(SZSE:002252)?
The next earnings date of Shanghai RAAS Blood Products Co Ltd(SZSE:002252) is .
Does Shanghai RAAS Blood Products Co Ltd(SZSE:002252) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai RAAS Blood Products Co Ltd(SZSE:002252) is 0.41% (As of Today), Highest Dividend Payout Ratio of Shanghai RAAS Blood Products Co Ltd(SZSE:002252) was 0.57. The lowest was 0.05. And the median was 0.16. The  Forward Dividend Yield % of Shanghai RAAS Blood Products Co Ltd(SZSE:002252) is 0.41%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers